Durvalumab trials for Carcinoma, Non-Small-Cell Lung

All Durvalumab trials · All Carcinoma, Non-Small-Cell Lung trials

Phase breakdown

Recruiting trials studying Durvalumab for Carcinoma, Non-Small-Cell Lung

• A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
  NCT06667908 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 43 locations
• Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung Cancer
  NCT04499053 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
  NCT06890598 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 369 locations

Common questions

How many trials study Durvalumab for Carcinoma, Non-Small-Cell Lung?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.